Latest News About Chobani, Llc

Here’s the latest publicly available overview of Chobani, LLC, based on recent reporting.

Short answer

• Chobani raised a substantial equity round in 2025 to fund US plant expansions, with a reported valuation around $20 billion; the company aims to accelerate production growth at facilities in New York and Idaho. This reflects ongoing diversification beyond yogurt into higher-protein and plant-based products. [Source: Reuters report on the 2025 funding round; New York Times DealBook reference][1]

Key developments

• Funding and expansion

  • In October 2025, Chobani announced a $650 million equity round to finance expansions at its New York and Idaho plants, targeting about a 50% increase in Idaho capacity and upgrades at the upstate New York facility. The round valued the company near $20 billion, signaling strong investor confidence in its growth trajectory.[1]
  • The capital influx was earmarked to support planned facility expansions and modernization, aligning with Chobani’s strategy to scale production to meet rising demand for higher-protein and diversified product lines.[2][1]

• Growth outlook

  • Chobani projected sales in the mid-to-high billions for 2025, up around the 28% year-over-year mark, reflecting ongoing top-line momentum despite broader market headwinds for dairy. This aligns with industry chatter about private food brands expanding share against larger incumbents.[2][1]

• Corporate strategy and diversification

  • Beyond core yogurt, the company has continued to broaden its product portfolio to include high-protein shakes and other dairy and plant-based offerings, aiming to capture new dayparts and usage occasions.[3][1]
  • Chobani has also pursued acquisitions and investments to complement its growth, including related dairy and plant-based ventures within recent years.[1][2]

• Market context

  • The yogurt and natural foods sector has seen heightened competition and shifting consumer preferences toward premium, protein-forward options; Chobani’s expansion plans position it to leverage scale and brand strength in this environment.[2][1]

Notable items you might want to monitor

• Planned completion timelines for the New York upstate facility upgrades and the Idaho plant expansion, along with any updates on total production capacity milestones.
• Any new product launches or line extensions tied to the company’s higher-protein and plant-based initiatives.
• Legal or regulatory developments affecting labeling, ingredients claims, or ongoing litigation as reported in late 2024–2025 periods, which could influence consumer perception and operations.[4]

Illustrative note

• If you’d like, I can summarize these developments in a concise one-page briefing or track them over time with a timeline and key milestones.

Citations

• Chobani funding and expansion plans reported by Reuters, including the $650 million round and $20 billion valuation.[1]
• NYT DealBook reference corroborating the valuation and sales outlook.[2]
• Additional context on product diversification and growth strategy cited from related coverage.[3][1]
• Public product and brand information from Chobani’s official site for context on mission and broader strategy.[5][7]

If you want, I can pull more recent articles or focus on a specific aspect (financials, plant development, product lines) and provide a side-by-side timeline.